{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:32:21Z","timestamp":1792783941253,"version":"4.5.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T00:00:00Z","timestamp":1502668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"European Community's Framework Programme","award":["278611"],"award-info":[{"award-number":["278611"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.freeradbiomed.2017.08.006","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T11:31:43Z","timestamp":1502710303000},"page":"387-396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"special_numbering":"C","title":["NADPH oxidases as drug targets and biomarkers in neurodegenerative diseases: What is the evidence?"],"prefix":"10.1016","volume":"112","author":[{"given":"Silvia","family":"Sorce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Stocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Seredenina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikard","family":"Holmdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Aguzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Chio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Depaulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy","family":"Heitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Olofsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venceslas","family":"Duveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Sanoudou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Skosgater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Vlahou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Wasquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Heinz","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Jaquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.08.006_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol. Rev."},{"issue":"7974","key":"10.1016\/j.freeradbiomed.2017.08.006_bib2","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(76)93021-X","article-title":"Characterisation of the enzyme defect in chronic granulomatous disease","volume":"1","author":"Segal","year":"1976","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.freeradbiomed.2017.08.006_bib3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1189\/jlb.0409243","article-title":"Editorial: genetic mapping--the path of discovery for novel functions of the NOX NADPH oxidases","volume":"86","author":"Jaquet","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.freeradbiomed.2017.08.006_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.redox.2015.07.009","article-title":"Genetic disorders coupled to ROS deficiency","volume":"6","author":"O'Neill","year":"2015","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.08.006_bib5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/imr.12378","article-title":"Ncf1 polymorphism reveals oxidative regulation of autoimmune chronic inflammation","volume":"269","author":"Holmdahl","year":"2016","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2017.08.006_bib6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcmgh.2015.06.005","article-title":"Defects in NADPH oxidase genes NOX1 and DUOX2 in very early onset inflammatory bowel disease","volume":"1","author":"Hayes","year":"2015","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2017.08.006_bib7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/ATVBAHA.116.307096","article-title":"Clarity on the isoform-specific roles of NADPH oxidases and NADPH oxidase-4 in atherosclerosis","volume":"36","author":"Fulton","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2017.08.006_bib8","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1053\/gast.2002.32409","article-title":"Neutrophils and NADPH oxidase mediate intrapancreatic trypsin activation in murine experimental acute pancreatitis","volume":"122","author":"Gukovskaya","year":"2002","journal-title":"Gastroenterology"},{"issue":"17","key":"10.1016\/j.freeradbiomed.2017.08.006_bib9","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1089\/ars.2013.5357","article-title":"NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy","volume":"20","author":"Wilkinson-Berka","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"17","key":"10.1016\/j.freeradbiomed.2017.08.006_bib10","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1089\/ars.2013.5703","article-title":"New insights on NOX enzymes in the central nervous system","volume":"20","author":"Nayernia","year":"2014","journal-title":"Antioxid. Redox Signal"},{"issue":"6248","key":"10.1016\/j.freeradbiomed.2017.08.006_bib11","doi-asserted-by":"crossref","first-page":"1255555","DOI":"10.1126\/science.1255555","article-title":"NEURODEGENERATION. Alzheimer's and Parkinson's diseases: the prion concept in relation to assembled Abeta, tau, and\u00a0alpha-synuclein","volume":"349","author":"Goedert","year":"2015","journal-title":"Science"},{"issue":"7628","key":"10.1016\/j.freeradbiomed.2017.08.006_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: from genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.freeradbiomed.2017.08.006_bib13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"6301","key":"10.1016\/j.freeradbiomed.2017.08.006_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.freeradbiomed.2017.08.006_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nrd3050","article-title":"Protein aggregation diseases: pathogenicity and therapeutic perspectives","volume":"9","author":"Aguzzi","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.freeradbiomed.2017.08.006_bib16","first-page":"CD006378","article-title":"Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease","volume":"2","author":"Jaturapatporn","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.08.006_bib17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrd.2015.14","article-title":"Central nervous system myeloid cells as drug targets: current status and translational challenges","volume":"15","author":"Biber","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2017.08.006_bib18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","article-title":"The role of oxidative stress in neurodegenerative diseases","volume":"24","author":"Kim","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.freeradbiomed.2017.08.006_bib19","article-title":"The oxidative stress theory of disease: levels of evidence and epistemological aspects","author":"Ghezzi","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2017.08.006_bib20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.redox.2016.12.035","article-title":"Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: oxidative eustress","volume":"11","author":"Sies","year":"2017","journal-title":"Redox Biol."},{"issue":"11","key":"10.1016\/j.freeradbiomed.2017.08.006_bib21","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1161\/01.STR.28.11.2252","article-title":"Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase","volume":"28","author":"Walder","year":"1997","journal-title":"Stroke"},{"issue":"14","key":"10.1016\/j.freeradbiomed.2017.08.006_bib22","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1007\/s00018-012-1014-5","article-title":"NOX enzymes in the central nervous system: therapeutic opportunities","volume":"69","author":"Sorce","year":"2012","journal-title":"Cell Mol. Life Sci."},{"issue":"10","key":"10.1016\/j.freeradbiomed.2017.08.006_bib23","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1089\/ars.2009.2578","article-title":"NOX enzymes in the central nervous system: from signaling to disease","volume":"11","author":"Sorce","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.freeradbiomed.2017.08.006_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.freeradbiomed.2016.05.016","article-title":"Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis","volume":"97","author":"Seredenina","year":"2016","journal-title":"Free Radic. Biol. Med."},{"issue":"36","key":"10.1016\/j.freeradbiomed.2017.08.006_bib25","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","article-title":"An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex","volume":"34","author":"Zhang","year":"2014","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.freeradbiomed.2017.08.006_bib26","doi-asserted-by":"crossref","first-page":"e1004531","DOI":"10.1371\/journal.ppat.1004531","article-title":"The role of the NADPH oxidase NOX2 in prion pathogenesis","volume":"10","author":"Sorce","year":"2014","journal-title":"PLoS Pathog."},{"issue":"41","key":"10.1016\/j.freeradbiomed.2017.08.006_bib27","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.2174\/1381612821666151029112302","article-title":"The role of NADPH oxidase in vascular disease--hypertension, atherosclerosis & stroke","volume":"21","author":"Gray","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.08.006_bib28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF02982713","article-title":"Macrophage-specific gene expression: current paradigms and future challenges","volume":"76","author":"Greaves","year":"2002","journal-title":"Int. J. Hematol."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2017.08.006_bib29","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1182\/blood.V73.6.1686.1686","article-title":"Characterization of two monoclonal antibodies against cytochrome b558 of human neutrophils","volume":"73","author":"Verhoeven","year":"1989","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.08.006_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nchembio.497","article-title":"Nox2 redox signaling maintains essential cell populations in the brain","volume":"7","author":"Dickinson","year":"2011","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.08.006_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.stem.2010.11.028","article-title":"Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K\/Akt-dependant manner","volume":"8","author":"Le Belle","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"42","key":"10.1016\/j.freeradbiomed.2017.08.006_bib32","doi-asserted-by":"crossref","first-page":"14465","DOI":"10.1523\/JNEUROSCI.2246-12.2012","article-title":"NADPH oxidase 1 mediates alpha-synucleinopathy in Parkinson's disease","volume":"32","author":"Cristovao","year":"2012","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2017.08.006_bib33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1159\/000369930","article-title":"Nox4 is a major source of superoxide production in human brain pericytes","volume":"51","author":"Kuroda","year":"2014","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.freeradbiomed.2017.08.006_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2016.07.005","article-title":"Oxidative stress: a major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease","volume":"147","author":"Jiang","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.freeradbiomed.2017.08.006_bib35","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1038\/ncomms5317","article-title":"The intracellular redox protein MICAL-1 regulates the development of hippocampal mossy fibre connections","volume":"5","author":"Van Battum","year":"2014","journal-title":"Nat. Commun."},{"issue":"25","key":"10.1016\/j.freeradbiomed.2017.08.006_bib36","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.2174\/138161210793176527","article-title":"Monoamine oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disorders","volume":"16","author":"Naoi","year":"2010","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2017.08.006_bib37","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/syn.20505","article-title":"Cytochrome P450 2E1 in the substantia nigra: relevance for dopaminergic neurotransmission and free radical production","volume":"62","author":"Shahabi","year":"2008","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.08.006_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13024-017-0150-7","article-title":"NADPH oxidase in brain injury and neurodegenerative disorders","volume":"12","author":"Ma","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.08.006_bib39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.nbd.2011.07.015","article-title":"Diapocynin and apocynin administration fails to significantly extend survival in G93A SOD1 ALS mice","volume":"45","author":"Trumbull","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2017.08.006_bib40","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.neulet.2011.01.077","article-title":"Apocynin administration does not improve behavioral and neuropathological deficits in a transgenic mouse model of Alzheimer's disease","volume":"492","author":"Dumont","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2017.08.006_bib41","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1089\/ars.2014.6202","article-title":"Discovery of GSK2795039, a novel small molecule NADPH oxidase 2 inhibitor","volume":"23","author":"Hirano","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.08.006_bib42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/HYPERTENSIONAHA.107.100214","article-title":"Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant","volume":"51","author":"Heumuller","year":"2008","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.08.006_bib43","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1089\/ars.2012.4886","article-title":"Methods for detection of mitochondrial and cellular reactive oxygen species","volume":"20","author":"Dikalov","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.08.006_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/14756366.2011.636360","article-title":"NADPH oxidase-dependent and -independent mechanisms of reported inhibitors of reactive oxygen generation","volume":"28","author":"Gatto","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.freeradbiomed.2017.08.006_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neulet.2014.09.042","article-title":"A novel mitochondrially-targeted apocynin derivative prevents hyposmia and loss of motor function in the leucine-rich repeat kinase 2 (LRRK2(R1441G)) transgenic mouse model of Parkinson's disease","volume":"583","author":"Dranka","year":"2014","journal-title":"Neurosci. Lett."},{"issue":"2b","key":"10.1016\/j.freeradbiomed.2017.08.006_bib46","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1476-5381.2011.01439.x","article-title":"NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action","volume":"164","author":"Jaquet","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2017.08.006_bib47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.freeradbiomed.2015.05.023","article-title":"A subset of N-substituted phenothiazines inhibits NADPH oxidases","volume":"86","author":"Seredenina","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"23","key":"10.1016\/j.freeradbiomed.2017.08.006_bib48","doi-asserted-by":"crossref","first-page":"16176","DOI":"10.1074\/jbc.M114.548693","article-title":"High-throughput assays for superoxide and hydrogen peroxide: design of a screening workflow to identify inhibitors of NADPH oxidases","volume":"289","author":"Zielonka","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.freeradbiomed.2017.08.006_bib49","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1089\/ars.2009.2585","article-title":"NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets","volume":"11","author":"Jaquet","year":"2009","journal-title":"Antioxid. Redox Signal."},{"issue":"Pt 1","key":"10.1016\/j.freeradbiomed.2017.08.006_bib50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1042\/bj2900041","article-title":"Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase","volume":"290","author":"O'Donnell","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.freeradbiomed.2017.08.006_bib51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.freeradbiomed.2016.11.019","article-title":"Cytochrome P450 enzymes but not NADPH oxidases are the source of the NADPH-dependent lucigenin chemiluminescence in membrane assays","volume":"102","author":"Rezende","year":"2017","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2017.08.006_bib52","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.chembiol.2012.04.015","article-title":"Ebselen and congeners inhibit NADPH oxidase 2-dependent superoxide generation by interrupting the binding of regulatory subunits","volume":"19","author":"Smith","year":"2012","journal-title":"Chem. Biol."},{"issue":"7","key":"10.1016\/j.freeradbiomed.2017.08.006_bib53","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1248\/bpb1978.13.421","article-title":"Mechanism for the inhibitory effect of a seleno-organic compound, Ebselen, and its analogues on superoxide anion production in guinea pig polymorphonuclear leukocytes","volume":"13","author":"Wakamura","year":"1990","journal-title":"J. Pharmacobio.-Dyn."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.08.006_bib54","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/01.STR.29.1.12","article-title":"Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group","volume":"29","author":"Yamaguchi","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.freeradbiomed.2017.08.006_bib55","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.abb.2015.10.024","article-title":"Ebselen, a useful tool for understanding cellular redox biology and a promising drug candidate for use in human diseases","volume":"595","author":"Noguchi","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"issue":"13","key":"10.1016\/j.freeradbiomed.2017.08.006_bib56","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1074\/jbc.M115.702787","article-title":"Mitigation of NADPH oxidase 2 activity as a strategy to inhibit peroxynitrite formation","volume":"291","author":"Zielonka","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.freeradbiomed.2017.08.006_bib57","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1021\/jm900592h","article-title":"6-methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors","volume":"52","author":"Cilibrizzi","year":"2009","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2017.08.006_bib58","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.bcp.2010.11.005","article-title":"Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library","volume":"81","author":"Forsman","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.08.006_bib59","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1124\/mol.109.060673","article-title":"Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition","volume":"77","author":"Kirpotina","year":"2010","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2017.08.006_bib60","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1124\/mol.106.033100","article-title":"High-throughput screening for small-molecule activators of neutrophils: identification of novel N-formyl peptide receptor agonists","volume":"71","author":"Schepetkin","year":"2007","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.08.006_bib61","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1124\/mol.108.046946","article-title":"Identification of novel formyl peptide receptor-like 1 agonists that induce macrophage tumor necrosis factor alpha production","volume":"74","author":"Schepetkin","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2017.08.006_bib62","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1089\/ars.2013.5788","article-title":"Pharmacological potential of NOX2 agonists in inflammatory conditions","volume":"23","author":"Hultqvist","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"10","key":"10.1016\/j.freeradbiomed.2017.08.006_bib63","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1172\/JCI31935","article-title":"Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species","volume":"117","author":"Gelderman","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.08.006_bib64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng1058","article-title":"Positional identification of Ncf1 as a gene that regulates arthritis severity in rats","volume":"33","author":"Olofsson","year":"2003","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.freeradbiomed.2017.08.006_bib65","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1089\/ars.2010.3440","article-title":"Positioning of a polymorphic quantitative trait nucleotide in the Ncf1 gene controlling oxidative burst response and arthritis severity in rats","volume":"14","author":"Hultqvist","year":"2011","journal-title":"Antioxid. Redox Signal."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2017.08.006_bib66","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ygeno.2003.10.005","article-title":"Inconsistent susceptibility to autoimmunity in inbred LEW rats is due to genetic crossbreeding involving segregation of the arthritis-regulating gene Ncf1","volume":"83","author":"Olofsson","year":"2004","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.freeradbiomed.2017.08.006_bib67","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/ars.2011.4013","article-title":"Copy number variation of the gene NCF1 is associated with rheumatoid arthritis","volume":"16","author":"Olsson","year":"2012","journal-title":"Antioxid. Redox Signal."},{"issue":"9","key":"10.1016\/j.freeradbiomed.2017.08.006_bib68","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1371\/journal.pmed.0030348","article-title":"A new arthritis therapy with oxidative burst inducers","volume":"3","author":"Hultqvist","year":"2006","journal-title":"PLoS Med."},{"issue":"10","key":"10.1016\/j.freeradbiomed.2017.08.006_bib69","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.4049\/jimmunol.176.10.6055","article-title":"Advanced intercross line mapping of Eae5 reveals Ncf-1 and CLDN4 as candidate genes for experimental autoimmune encephalomyelitis","volume":"176","author":"Becanovic","year":"2006","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.freeradbiomed.2017.08.006_bib70","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.4049\/jimmunol.0803847","article-title":"Advanced intercross line mapping suggests thatncf1 (ean6) regulates severity in an animal model of guillain-barre syndrome","volume":"182","author":"Huberle","year":"2009","journal-title":"J. Immunol."},{"issue":"34","key":"10.1016\/j.freeradbiomed.2017.08.006_bib71","doi-asserted-by":"crossref","first-page":"12646","DOI":"10.1073\/pnas.0403831101","article-title":"Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene","volume":"101","author":"Hultqvist","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"35","key":"10.1016\/j.freeradbiomed.2017.08.006_bib72","doi-asserted-by":"crossref","first-page":"E3669","DOI":"10.1073\/pnas.1405798111","article-title":"Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice","volume":"111","author":"Khmaladze","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"16","key":"10.1016\/j.freeradbiomed.2017.08.006_bib73","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1089\/ars.2013.5828","article-title":"Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature","volume":"21","author":"Kelkka","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"7523","key":"10.1016\/j.freeradbiomed.2017.08.006_bib74","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1038\/nature13844","article-title":"Tryptophan catabolism is unaffected in chronic granulomatous disease","volume":"514","author":"Maghzal","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.freeradbiomed.2017.08.006_bib75","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nm.3547","article-title":"Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines","volume":"20","author":"Schauer","year":"2014","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.08.006_bib76","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00401-014-1263-5","article-title":"Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models","volume":"128","author":"Schuh","year":"2014","journal-title":"Acta Neuropathol."},{"issue":"10","key":"10.1016\/j.freeradbiomed.2017.08.006_bib77","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1172\/JCI31265","article-title":"Redox modifier genes in amyotrophic lateral sclerosis in mice","volume":"117","author":"Marden","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2017.08.006_bib78","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1152\/physrev.00006.2009","article-title":"Prions: protein aggregation and infectious diseases","volume":"89","author":"Aguzzi","year":"2009","journal-title":"Physiol. Rev."},{"issue":"7465","key":"10.1016\/j.freeradbiomed.2017.08.006_bib79","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12402","article-title":"The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein","volume":"501","author":"Sonati","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.08.006_bib80","doi-asserted-by":"crossref","first-page":"e1004662","DOI":"10.1371\/journal.ppat.1004662","article-title":"Prion infections and anti-PrP antibodies trigger converging neurotoxic pathways","volume":"11","author":"Herrmann","year":"2015","journal-title":"PLoS Pathog."},{"issue":"15","key":"10.1016\/j.freeradbiomed.2017.08.006_bib81","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1089\/ars.2015.6565","article-title":"Response to pick","volume":"23","author":"Jaquet","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"10","key":"10.1016\/j.freeradbiomed.2017.08.006_bib82","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.freeradbiomed.2012.09.002","article-title":"Detection of reactive oxygen species derived from the family of NOX NADPH oxidases","volume":"53","author":"Maghzal","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"7","key":"10.1016\/j.freeradbiomed.2017.08.006_bib83","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1089\/ars.2015.6314","article-title":"Unchanged NADPH oxidase activity in Nox1-Nox2-Nox4 triple knockout mice: what do NADPH-stimulated chemiluminescence assays really detect?","volume":"24","author":"Rezende","year":"2016","journal-title":"Antioxid. Redox Signal."},{"issue":"8","key":"10.1016\/j.freeradbiomed.2017.08.006_bib84","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.freeradbiomed.2010.01.028","article-title":"Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth","volume":"48","author":"Zielonka","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2017.08.006_bib85","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.HYP.0000258594.87211.6b","article-title":"Measurement of reactive oxygen species in cardiovascular studies","volume":"49","author":"Dikalov","year":"2007","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.freeradbiomed.2017.08.006_bib86","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1007\/s00415-014-7470-0","article-title":"NADPH oxidase (NOX2) activity is a modifier of survival in ALS","volume":"261","author":"Marrali","year":"2014","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2017.08.006_bib87","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/ene.12971","article-title":"NADPH oxidase 2 (NOX2) enzyme activation in patients with chronic inflammatory demyelinating polyneuropathy","volume":"23","author":"Marrali","year":"2016","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2017.08.006_bib88","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1212\/NXI.0000000000000256","article-title":"Absence of systemic oxidative stress and increased CSF prostaglandin F2alpha in progressive MS","volume":"3","author":"Lam","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2017.08.006_bib89","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40265-015-0528-1","article-title":"A review in relapsing-remitting MS","volume":"76","author":"Deeks","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.freeradbiomed.2017.08.006_bib90","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mcn.2012.11.011","article-title":"Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases","volume":"55","author":"Chaturvedi","year":"2013","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.freeradbiomed.2017.08.006_bib91","article-title":"Neuronal protection against oxidative insult by polyanhydride nanoparticle-based mitochondria-targeted antioxidant therapy","author":"Brenza","year":"2016","journal-title":"Nanomedicine"},{"issue":"Pt 9","key":"10.1016\/j.freeradbiomed.2017.08.006_bib92","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1093\/brain\/awv184","article-title":"Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease","volume":"138","author":"Jucaite","year":"2015","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.freeradbiomed.2017.08.006_bib93","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cell.2013.12.035","article-title":"Redox modification of nuclear actin by MICAL-2 regulates SRF signaling","volume":"156","author":"Lundquist","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.freeradbiomed.2017.08.006_bib94","article-title":"Microglia antioxidant systems and redox signaling","author":"Vilhardt","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"7631","key":"10.1016\/j.freeradbiomed.2017.08.006_bib95","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nature.2016.21045","article-title":"Failed Alzheimer's trial does not kill leading theory of disease","volume":"540","author":"Abbott","year":"2016","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.freeradbiomed.2017.08.006_bib96","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.freeradbiomed.2017.08.006_bib97","doi-asserted-by":"crossref","first-page":"i6771","DOI":"10.1136\/bmj.i6771","article-title":"Solanezumab and the amyloid hypothesis for Alzheimer's disease","volume":"355","author":"Le Couteur","year":"2016","journal-title":"Br. Med. J."},{"key":"10.1016\/j.freeradbiomed.2017.08.006_bib98","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.redox.2017.04.026","article-title":"Decreased neural precursor cell pool in NADPH oxidase 2-deficiency: From mouse brain to neural differentiation of patient derived iPSC","volume":"13","author":"Nayernia","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.freeradbiomed.2017.08.006_bib99","unstructured":"K.F. Wallner, J.P. Olofsson, M.K. Malin Kristin Hultqvist, B.H. Pelcman, Quinolinone derivatives for use in the treatment of an autoimmune disease and\/or an inflammatory disease. WO 2012127214 A1 (2012)."}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584917307220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584917307220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:51:27Z","timestamp":1760205087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891584917307220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":99,"alternative-id":["S0891584917307220"],"URL":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.08.006","relation":{},"ISSN":["0891-5849"],"issn-type":[{"value":"0891-5849","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NADPH oxidases as drug targets and biomarkers in neurodegenerative diseases: What is the evidence?","name":"articletitle","label":"Article Title"},{"value":"Free Radical Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}